Navigation Links
ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA
Date:9/10/2007

SAN DIEGO, Sept. 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases, announced today that it has received confirmation from the U.S. Food and Drug Administration (FDA) regarding its proposed 505(b)(2) New Drug Application (NDA) regulatory path for ANX-514 (docetaxel emulsion). The FDA has indicated that data from a single study of approximately 28 patients that demonstrates the bioequivalence of ANX-514 and docetaxel is sufficient to support filing an NDA. Docetaxel is an anti-cancer agent that is approved to treat breast, non-small cell lung, prostate, gastric and head and neck cancers, and is marketed under the brand name Taxotere(R). Annual sales of Taxotere in 2006 were approximately $2.2 billion.

"This guidance from the FDA is significant as conducting a single marketing-enabling trial provides us a clear and direct clinical path and substantially shortens the timelines for clinical development and submitting an NDA for ANX-514," said Evan M. Levine, chief executive officer of ADVENTRX. "Pending appropriate clearances, we look forward to starting the proposed bioequivalence trial later this year."

The Company currently plans to submit an investigational new drug (IND) application in the fourth quarter of 2007. The proposed clinical trial will compare the blood levels of docetaxel following a single dose of ANX-514 or Taxotere in patients with advanced cancers. In addition, the Company plans to analyze the safety of ANX-514.

ANX-514 Preclinical Results

Preclinical results have demonstrated equivalent pharmacoki
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ROCKVILLE, Md., Nov. 20 ...t it has priced an underwritten public offering of...o the public of $3.30 per share. The approximatel... underwriting discounts and commissions, will be u... our VLP-based vaccines, internal research and dev...
(Date:11/20/2009)... METTLER TOLEDO recently announced tha...s Optimization Using At-Line Particle Characteriza.... In this webinar, the application of in situ par...design space and optimize a series of roller compa..., and roller compaction forces. , ...
(Date:11/19/2009)...ENHAGEN, Nov. 19 Danish Prince Joa...losic ethanol plant in Kalundborg, Denmark, on Wed...rld,s first and largest 2nd generation ethanol dem...nzymes are used in the plant,s innovative process ... of Danisco, was the first to market with commerci...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-First... innovator in biotechnology for diabetes therapy, ...ing services to food, supplement, biotechnology an...sed the previously reported $6.3 million registere...,760,870 shares of its common stock and warrants t...
Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
...OKYO, Japan, April 28 HOYA Corporation today,anno...n for the period,ended March 31, 2008, a 36.5% inc...rating income for the quarter was 18.0 billion yen...in the prior year period. Net,income for the fourt...are,were 37.71 yen. For the same quarter of the pr...
... Vaccine for new strain of virus broadens governme... France, April 28 ,Sanofi Pasteur, the vaccines di...at the U.S. Department of Health and Human Service...produce approximately 38.5 million,doses of vaccin...za. Sanofi,Pasteur has a multi- year contract with...
...ANJING, CHINA, April 28 Simcere,Pharmaceutical Gr...lier of,branded generic pharmaceuticals and manufa... Endu in China, today announced that it has been,i... Good Management,Limited, a British Virgin Islands...luding certain senior management of Simcere Pharma...
Other Biology Technology:Hoya Announces Fourth Quarter and FY2007 Financial Results 2Hoya Announces Fourth Quarter and FY2007 Financial Results 3U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile 2U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile 3U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile 4Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder 2Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder 3
(Date:11/23/2009)...controvertible evidence" that the volcanic super-e...000 years ago deforested much of central India, so...ort. , The volcano ejected an estimated 800 cubi... crater (now the world,s largest volcanic lake) th...Ash from the event has been found in India, the In...
(Date:11/23/2009)...sity of Alabama at Birmingham (UAB) researchers sh...ical conditions (co-morbidity) do not explain the ...s compared to Caucasians who also have colon cance...r , a journal of the American Cancer Society. , ...bidity are independent predictors of poor survival...
(Date:11/23/2009)...ries about the multiple health benefits of vitamin...ient, increased awareness of the huge numbers of p...d even led to an appreciation of it as "nature,s a...of your immune system to prevention of heart disea...is now seen as one of the most critical nutrients ...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Par Pharmaceutical Receives Final Approval To Market Generic Starlix 28R 29 56816 1Par Pharmaceutical Receives Final Approval To Market Generic Starlix 28R 29 56816 2SRI Internationals Research on Nicotine Use and Dependence Featured in the National Cancer Institutes Tobacco Control Monograph Series 56811 1SRI Internationals Research on Nicotine Use and Dependence Featured in the National Cancer Institutes Tobacco Control Monograph Series 56811 2SRI Internationals Research on Nicotine Use and Dependence Featured in the National Cancer Institutes Tobacco Control Monograph Series 56811 3FDA Issues Complete Response Letter For Trabectedin Combined With DOXIL 13986 1FDA Issues Complete Response Letter For Trabectedin Combined With DOXIL 13986 2
...al Center have identified a previously unknown fam...esponsible for the plague especially efficient at ...nly demonstrated that the use of the common roundw... Yersinia pestis, the bacterium that causes plague... pestis and the worm is quite similar to what occu...
...ege are using tobacco plants to produce monoclonal...t can target and hunt down cancer cells. The plant...roducing anticancer antibodies, raising hopes that...cientists, led by Hilary Koprowski, M.D., professo...he Biotechnology Foundation Laboratories and the C...
...have made significant new advances in determining ...covery that in one sense takes up where Watson and...e-helical structure of this biological blueprint f...hemistry is to predict the structure of a molecule...he "Holy Grail" of protein chemistry. , Today, th...
Other Biology News:Novel plague virulence factor identified 2Novel plague virulence factor identified 3Novel plague virulence factor identified 4Scientists turn tobacco against cancer 2Major advance made on DNA structure 2Major advance made on DNA structure 3
21-mer duplex from B-Bridge International
...s the first fully genetically encoded fluorescent ...acellular hydrogen peroxide (H2O2), one of the mai...f yellow fluorescent protein inserted into the reg...xyR-RD), HyPer demonstrates submicromolar affinity...
Mouse Anti-Mouse Qa-2 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone 695H1-9-9 from BioLegend
Luminex 100 Instrument System from Upstate
Biology Products: